MétaCan
Menu
Back to cohort
Record W4402574542 · doi:10.1136/jnnp-2024-333819

Neuropsychiatric symptoms in cognitive decline and Alzheimer’s disease: biomarker discovery using plasma proteomics

2024· article· en· W4402574542 on OpenAlexfundno aff
Miriam Rabl, Christopher Clark, Loı̈c Dayon, Julius Popp

Bibliographic record

VenueJournal of Neurology Neurosurgery & Psychiatry · 2024
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsnot available
FundersJohnson and Johnson Pharmaceutical Research and DevelopmentJanssen PharmaceuticalsNIH Clinical CenterNational Institute on AgingEisai IncorporatedCanadian Institutes of Health ResearchGenentechTakeda Pharmaceutical CompanyIXICOGE HealthcareStiftung Synapsis - Alzheimer Forschung Schweiz AFSUniversität ZürichServierEli Lilly and CompanyLundbeckfondenSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungNorthern California Institute for Research and EducationBioClinicaBiogenPfizerNovartis Pharmaceuticals CorporationDefense Health AgencyBristol-Myers SquibbAlzheimer's AssociationFujirebio USMeso Scale DiagnosticsAbbVieMerckFoundation for the National Institutes of Health
KeywordsBiomarkerDementiaDiseaseCognitive declineMedicineLogistic regressionInternal medicineOncologyCohortAlzheimer's diseaseReceiver operating characteristicArea under the curveCerebrospinal fluidCognitive impairmentCognitionNeuroimagingAlzheimer's Disease Neuroimaging InitiativePsychiatryBiologyBiochemistry

Abstract

fetched live from OpenAlex

BACKGROUND AND OBJECTIVES: Neuropsychiatric symptoms (NPS) are common in older people with cognitive impairment and Alzheimer's disease (AD). No biomarkers to detect the related pathology or predict the clinical evolution of NPS are available yet. This study aimed to identify plasma proteins that may serve as biomarkers for NPS and NPS-related clinical disease progression. METHODS: A panel of 190 plasma proteins was quantified using Luminex xMAP in the Alzheimer's Disease Neuroimaging Initiative cohort. NPS and cognitive performance were assessed at baseline and after 1 and 2 years. Logistic regression, receiver operating characteristic analysis and cross-validation were used to address the relations of interest. RESULTS: A total of 507 participants with mild cognitive impairment (n=396) or mild AD dementia (n=111) were considered. Selected plasma proteins improved the prediction of NPS (area under the curve (AUC) from 0.61 to 0.76, p<0.001) and future NPS (AUC from 0.63 to 0.80, p<0.001) when added to a reference model. Distinct protein panels were identified for single symptoms. Among the selected proteins, ANGT, CCL1 and IL3 were associated with NPS at all three time points while CCL1, serum glutamic oxaloacetic transaminase and complement factor H were also associated with cognitive decline. The associations were independent of the presence of cerebral AD pathology as assessed using cerebrospinal fluid biomarkers. CONCLUSIONS: Plasma proteins are associated with NPS and improve prediction of future NPS.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.030
GPT teacher head0.335
Teacher spread0.305 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations15
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Neurology Neurosurgery & PsychiatrySame topicDementia and Cognitive Impairment ResearchFrench-language works237,207